High-affinity binding sites for human Glu-plasminogen unveiled by limited plasmic degradation of human fibrin.

The binding of human 125I-Glu-plasminogen to human plasmin-degraded fibrin was studied. Treatment of preformed and polymerized fibrin with 0.01 IU plasmin/ml resulted in an increased binding of 125I-Glu-plasminogen depending upon the length of time of preincubation of fibrin with plasmin. Binding reached a plateau of 30% of total added radioactivity after 60 min. At this time, less than 10% of fibrin had been digested. Polyacrylamide/urea/acetic acid gel electrophoresis revealed that the radioiodinated plasminogen bound to plasmin-degraded fibrin was of the Glu form. Computerized non-linear regression analysis of the binding experiments revealed that limited plasmic degradation of fibrin progressively generates high-affinity binding sites (Kd approximately equal to 0.3 microM) for Glu-plasminogen. At the time of maximal Glu-plasminogen binding approximately 5 high-affinity binding sites per 100 molecules of fibrin had been generated. The low-affinity type of binding sites were also identified. These observations describe a new mechanism which exquisitely modulates the plasmic breakdown of fibrin by a continuous renewal of high-affinity binding sites for Glu-plasminogen on the surface of the fibrin gel during the fibrinolytic process.

[1]  T. Wun,et al.  Spontaneous fibrinolysis in whole human plasma. Identification of tissue activator-related protein as the major plasminogen activator causing spontaneous activity in vitro. , 1985, The Journal of biological chemistry.

[2]  P. Harpel,et al.  Tissue plasminogen activator and urokinase mediate the binding of Glu-plasminogen to plasma fibrin I. Evidence for new binding sites in plasmin-degraded fibrin I. , 1985, The Journal of biological chemistry.

[3]  U. Christensen C‐terminal lysine residues of fibrinogen fragments essential for binding to plasminogen , 1985, FEBS letters.

[4]  E. Kruithof,et al.  Tissue-type plasminogen activator increases the binding of glu-plasminogen to clots. , 1984, The Journal of clinical investigation.

[5]  S. Thorsen,et al.  Sequence of formation of molecular forms of plasminogen and plasmin-inhibitor complexes in plasma activated by urokinase or tissue-type plasminogen activator. , 1984, The Biochemical journal.

[6]  T. Edgington,et al.  Conformation of the carboxy-terminal region of the A alpha chain of fibrinogen as elucidated by immunochemical analyses. , 1984, European journal of biochemistry.

[7]  E. Kruithof,et al.  The mechanism of in vitro clot lysis induced by vascular plasminogen activator. , 1984, Blood.

[8]  J. Mimuro,et al.  Differential binding of plasminogen to crosslinked and noncrosslinked fibrins: its significance in hemostatic defect in factor XIII deficiency. , 1984, Blood.

[9]  L. Patthy,et al.  Importance of intramolecular interactions in the control of the fibrin affinity and activation of human plasminogen. , 1984, The Journal of biological chemistry.

[10]  S. Thorsen,et al.  Initial plasmin-degradation of fibrin as the basis of a positive feed-back mechanism in fibrinolysis. , 1984, European journal of biochemistry.

[11]  E. Bürgisser Radioligand—receptor binding studies: what's wrong with the scatchard analysis? , 1984 .

[12]  P. McKee,et al.  THE RELATIONSHIP OF FIBRINOGEN STRUCTURE TO PLASMINOGEN ACTIVATION AND PLASMIN ACTIVITY DURING FIBRINOLYSIS * , 1983, Annals of the New York Academy of Sciences.

[13]  P. McKee,et al.  The binding of human plasminogen to fibrin and fibrinogen. , 1983, The Journal of biological chemistry.

[14]  D. Collen,et al.  Measurement of human tissue-type plasminogen activator by a two-site immunoradiometric assay. , 1983, The Journal of laboratory and clinical medicine.

[15]  I. M. Klotz Ligand-receptor interactions: what we can and cannot learn from binding measurements , 1983 .

[16]  S. Thorsen,et al.  Secondary-site binding of Glu-plasmin, Lys-plasmin and miniplasmin to fibrin. , 1981, The Biochemical journal.

[17]  E. Shaw,et al.  Inactivation of trypsin-like enzymes with peptides of arginine chloromethyl ketone. , 1981, Methods in enzymology.

[18]  P. Gaffney,et al.  Preparation and stability of a highly purified human thrombin standard. , 1980, Thrombosis research.

[19]  P. Ottolenghi,et al.  Scatchard plot: common misinterpretation of binding experiments. , 1980, Analytical biochemistry.

[20]  R. Doolittle,et al.  The amino acid sequence of the α-chain of human fibrinogen , 1979, Nature.

[21]  A. Granelli‐Piperno,et al.  A study of proteases and protease-inhibitor complexes in biological fluids , 1978, The Journal of experimental medicine.

[22]  B. Wiman,et al.  On the kinetics of the reaction between human antiplasmin and plasmin. , 1978, European journal of biochemistry.

[23]  J. Hermans,et al.  Early events in the plasmin digestion of fibrinogen and fibrin. Effects of plasmin on fibrin polymerization. , 1977, The Journal of biological chemistry.

[24]  B. Violand,et al.  Mechanism of the urokinase-catalyzed activation of human plasminogen. , 1976, The Journal of biological chemistry.

[25]  H. G. Weder,et al.  Determination of binding parameters from Scatchard plots. Theoretical and practical considerations. , 1974, European journal of biochemistry.

[26]  E. Shaw,et al.  [2] Titration of trypsin, plasmin, and thrombin with p-nitrophenyl p′-guanidinobenzoate HCl☆ , 1970 .

[27]  R. Chalkley,et al.  High resolution acrylamide gel electrophoresis of histones. , 1969, Archives of biochemistry and biophysics.

[28]  G. Scatchard,et al.  THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS , 1949 .